EUVIMEDEUVIMED entdecken
Crossref

Unraveling the Interplay of 5-hydroxytryptamine-3 and N-methyl-d-aspartate Receptors in Seizure Susceptibility

Samane Jahanabadi iD, Mohammadreza Riahi Madvar

Drug Research · 01.11.2024 · 74 (09) · 456-463

DOI: 10.1055/a-2406-5340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Research, erschienen am 01.11.2024. Verfasst von Samane Jahanabadi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate, Tropisetron, Seizures, Pentylenetetrazole. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epilepsy, a prevalent neurological disorder characterized by recurrent seizures, presents significant challenges in treatment and management. This study aimed to evaluate the effect of tropisetron, a selective 5-HT3 receptor antagonist on pentylenetetrazole (PTZ) – induced seizure in mice by exploring the potential role of the NMDA receptor and inflammatory responses.

Methods

For this purpose, seizures were induced by intravenous PTZ infusion. Tropisetron at 1-, 2-, 3-, 5-, 10- mg/kg were administered intraperitoneally 30 minutes before PTZ. To evaluate probable role of NMDA signaling, selective NMDAR antagonists, ketamine and MK-801, were injected 15 minutes before tropisetron. Also, TNF-α level of hippocampus were measured following administration of mentioned drugs in mice.

Results

Our results demonstrate that tropisetron displayed a dose-dependent impact on seizure threshold, with certain doses (5 and 10 mg/kg) exhibiting anticonvulsant properties. In addition, the noncompetitive NMDAR antagonists, ketamine (1 mg/kg) and MK-801 (0.5 mg/kg), at doses that had no effect on seizure threshold, augmented the anticonvulsant effect of tropisetron (3 mg/kg). Also, tropisetron led to a reduction in hippocampal TNF-α levels, indicating its anti-inflammatory potential independent of 5-HT receptor activity.

Conclusion

In conclusion, we demonstrated that the anticonvulsant effect of tropisetron is mediated by the inhibition of NMDA receptors and a decline in hippocampal TNF-α level. These findings highlight a potential connection between 5-HT3 and NMDA receptors in the pharmacological treatment of inflammatory diseases, such as seizure, warranting further investigation into their combined therapeutic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, N-Methyl-D-AspartateTropisetronSeizuresPentylenetetrazoleHippocampusAnticonvulsantsKetamineTumor Necrosis Factor-alphaDizocilpine MaleateAnimalsMiceMaleReceptors, Serotonin, 5-HT3Serotonin 5-HT3 Receptor AntagonistsDisease Models, AnimalDose-Response Relationship, Drug

Substanzen

Receptors, N-Methyl-D-AspartateTropisetronPentylenetetrazoleAnticonvulsantsKetamineTumor Necrosis Factor-alphaDizocilpine MaleateReceptors, Serotonin, 5-HT3Serotonin 5-HT3 Receptor Antagonists

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Pharmaceutical Science Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

ORCID-Profile: Samane Jahanabadi

Zitieren

APA

Jahanabadi, S., & Madvar, M. R. (2024). Unraveling the Interplay of 5-hydroxytryptamine-3 and N-methyl-d-aspartate Receptors in Seizure Susceptibility. Drug Research, 74(09), 456-463. https://doi.org/10.1055/a-2406-5340

Vancouver

Jahanabadi S, Madvar MR. Unraveling the Interplay of 5-hydroxytryptamine-3 and N-methyl-d-aspartate Receptors in Seizure Susceptibility. Drug Research. 2024;74(09):456-463. doi:10.1055/a-2406-5340

BibTeX
@article{Jahanabadi2024,
  author = {Jahanabadi, Samane and Madvar, Mohammadreza Riahi},
  title = {Unraveling the Interplay of 5-hydroxytryptamine-3 and N-methyl-d-aspartate Receptors in Seizure Susceptibility},
  journal = {Drug Research},
  year = {2024},
  volume = {74},
  number = {09},
  pages = {456--463},
  doi = {10.1055/a-2406-5340}
}
Kostenlos starten →